Vasile Foris, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Hypertension, Pulmonary | 24 | 2024 | 1604 | 2.350 |
Why?
|
Pulmonary Artery | 10 | 2024 | 1944 | 0.650 |
Why?
|
Scleroderma, Systemic | 3 | 2021 | 346 | 0.380 |
Why?
|
Pulmonary Fibrosis | 3 | 2024 | 505 | 0.370 |
Why?
|
Vascular Resistance | 5 | 2023 | 939 | 0.360 |
Why?
|
Myositis | 1 | 2013 | 268 | 0.350 |
Why?
|
Leukocytes, Mononuclear | 2 | 2022 | 1854 | 0.350 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 5 | 2024 | 3253 | 0.310 |
Why?
|
Lung | 9 | 2024 | 10076 | 0.300 |
Why?
|
Exercise | 6 | 2024 | 5954 | 0.260 |
Why?
|
Autoantibodies | 1 | 2013 | 2114 | 0.240 |
Why?
|
Natriuretic Peptide, Brain | 1 | 2013 | 1749 | 0.230 |
Why?
|
Lung Diseases, Interstitial | 2 | 2023 | 940 | 0.230 |
Why?
|
Exercise Tolerance | 2 | 2022 | 846 | 0.220 |
Why?
|
Vascular Diseases | 2 | 2022 | 1161 | 0.220 |
Why?
|
Pulmonary Veno-Occlusive Disease | 1 | 2023 | 64 | 0.220 |
Why?
|
Endothelial Cells | 5 | 2024 | 3582 | 0.200 |
Why?
|
Hepatopulmonary Syndrome | 1 | 2022 | 25 | 0.200 |
Why?
|
Myocytes, Smooth Muscle | 2 | 2024 | 701 | 0.190 |
Why?
|
Scleroderma, Limited | 1 | 2021 | 8 | 0.190 |
Why?
|
Proteoglycans | 1 | 2024 | 807 | 0.180 |
Why?
|
Raynaud Disease | 1 | 2021 | 81 | 0.180 |
Why?
|
GATA6 Transcription Factor | 1 | 2020 | 54 | 0.180 |
Why?
|
Peptide Fragments | 1 | 2013 | 5141 | 0.180 |
Why?
|
Probiotics | 1 | 2024 | 387 | 0.180 |
Why?
|
Bone Morphogenetic Protein Receptors, Type II | 1 | 2020 | 72 | 0.170 |
Why?
|
Cell Separation | 3 | 2016 | 1717 | 0.160 |
Why?
|
Muscle, Smooth, Vascular | 2 | 2024 | 1493 | 0.150 |
Why?
|
Kynurenine | 1 | 2017 | 142 | 0.140 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2023 | 1144 | 0.130 |
Why?
|
Receptors, Interleukin-8B | 1 | 2016 | 58 | 0.130 |
Why?
|
Lung Diseases | 2 | 2024 | 1942 | 0.130 |
Why?
|
SOXB1 Transcription Factors | 1 | 2016 | 283 | 0.120 |
Why?
|
Cardiac Output | 3 | 2024 | 837 | 0.110 |
Why?
|
Hemodynamics | 5 | 2024 | 4186 | 0.110 |
Why?
|
Pulmonary Wedge Pressure | 1 | 2014 | 277 | 0.110 |
Why?
|
Proto-Oncogene Proteins c-kit | 1 | 2016 | 723 | 0.100 |
Why?
|
Growth Differentiation Factor 15 | 1 | 2013 | 199 | 0.100 |
Why?
|
Cell Proliferation | 3 | 2020 | 10455 | 0.090 |
Why?
|
Osteopontin | 1 | 2013 | 305 | 0.090 |
Why?
|
Prognosis | 7 | 2024 | 29963 | 0.090 |
Why?
|
Gamma Rays | 2 | 2010 | 324 | 0.090 |
Why?
|
Severity of Illness Index | 2 | 2024 | 15925 | 0.080 |
Why?
|
Flow Cytometry | 2 | 2018 | 5891 | 0.080 |
Why?
|
Mesenchymal Stem Cells | 2 | 2010 | 1665 | 0.080 |
Why?
|
Humans | 34 | 2024 | 767040 | 0.080 |
Why?
|
Austria | 2 | 2018 | 207 | 0.070 |
Why?
|
Aged | 12 | 2024 | 171319 | 0.070 |
Why?
|
Osteoblasts | 2 | 2010 | 1145 | 0.070 |
Why?
|
Middle Aged | 15 | 2024 | 223233 | 0.070 |
Why?
|
Inflammation | 2 | 2018 | 10869 | 0.070 |
Why?
|
Insulin Resistance | 1 | 2020 | 3986 | 0.070 |
Why?
|
Biglycan | 1 | 2024 | 10 | 0.060 |
Why?
|
Collagen | 2 | 2023 | 2636 | 0.060 |
Why?
|
Decorin | 1 | 2024 | 38 | 0.060 |
Why?
|
Female | 17 | 2024 | 396660 | 0.060 |
Why?
|
Thrombomodulin | 1 | 2024 | 107 | 0.060 |
Why?
|
Male | 16 | 2024 | 364203 | 0.060 |
Why?
|
Electrocardiography | 1 | 2016 | 6409 | 0.050 |
Why?
|
Peritoneal Neoplasms | 1 | 2010 | 706 | 0.050 |
Why?
|
Stem Cells | 1 | 2016 | 3535 | 0.050 |
Why?
|
Airway Remodeling | 1 | 2024 | 133 | 0.050 |
Why?
|
Chemokine CXCL9 | 1 | 2022 | 135 | 0.050 |
Why?
|
Cardiovascular Diseases | 2 | 2021 | 15645 | 0.050 |
Why?
|
Exercise Test | 2 | 2022 | 2188 | 0.050 |
Why?
|
Neoplastic Stem Cells | 1 | 2010 | 1349 | 0.050 |
Why?
|
Interleukin-15 | 1 | 2022 | 186 | 0.050 |
Why?
|
STAT1 Transcription Factor | 1 | 2022 | 341 | 0.050 |
Why?
|
Retrospective Studies | 8 | 2024 | 81659 | 0.050 |
Why?
|
Endothelium | 1 | 2023 | 768 | 0.040 |
Why?
|
Pulmonary Embolism | 1 | 2014 | 2598 | 0.040 |
Why?
|
von Willebrand Factor | 1 | 2024 | 680 | 0.040 |
Why?
|
Emphysema | 1 | 2023 | 237 | 0.040 |
Why?
|
Cobalt Radioisotopes | 2 | 2010 | 75 | 0.040 |
Why?
|
Cadherins | 1 | 2024 | 903 | 0.040 |
Why?
|
Immunophenotyping | 2 | 2018 | 1864 | 0.040 |
Why?
|
Natural Killer T-Cells | 1 | 2022 | 319 | 0.040 |
Why?
|
Cytokines | 1 | 2014 | 7446 | 0.040 |
Why?
|
Integrins | 1 | 2023 | 840 | 0.040 |
Why?
|
Antigens, CD | 2 | 2024 | 4032 | 0.040 |
Why?
|
Spheroids, Cellular | 2 | 2010 | 328 | 0.040 |
Why?
|
Adult | 8 | 2024 | 223317 | 0.040 |
Why?
|
Feces | 1 | 2024 | 1508 | 0.040 |
Why?
|
Cell Adhesion | 1 | 2024 | 3093 | 0.040 |
Why?
|
Arginine | 1 | 2021 | 931 | 0.040 |
Why?
|
Metabolome | 1 | 2024 | 1008 | 0.040 |
Why?
|
Pulmonary Emphysema | 1 | 2023 | 689 | 0.040 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2010 | 2330 | 0.040 |
Why?
|
Predictive Value of Tests | 3 | 2020 | 15424 | 0.030 |
Why?
|
Extracellular Matrix | 1 | 2024 | 1733 | 0.030 |
Why?
|
Head and Neck Neoplasms | 1 | 2010 | 2930 | 0.030 |
Why?
|
Walking | 1 | 2022 | 1201 | 0.030 |
Why?
|
Principal Component Analysis | 1 | 2018 | 950 | 0.030 |
Why?
|
Models, Animal | 1 | 2020 | 2121 | 0.030 |
Why?
|
Liver Neoplasms | 1 | 2010 | 4357 | 0.030 |
Why?
|
Aged, 80 and over | 2 | 2016 | 59548 | 0.030 |
Why?
|
Fibroblasts | 1 | 2024 | 4167 | 0.030 |
Why?
|
Vasodilator Agents | 1 | 2017 | 988 | 0.030 |
Why?
|
Adaptive Immunity | 1 | 2018 | 733 | 0.030 |
Why?
|
Ovarian Neoplasms | 1 | 2010 | 4903 | 0.030 |
Why?
|
Young Adult | 2 | 2017 | 59980 | 0.030 |
Why?
|
Endothelium, Vascular | 1 | 2024 | 4424 | 0.020 |
Why?
|
Rest | 1 | 2017 | 941 | 0.020 |
Why?
|
Tumor Cells, Cultured | 2 | 2010 | 6106 | 0.020 |
Why?
|
Liver Cirrhosis | 1 | 2022 | 1959 | 0.020 |
Why?
|
Heart Diseases | 1 | 2024 | 2817 | 0.020 |
Why?
|
Pilot Projects | 1 | 2024 | 8732 | 0.020 |
Why?
|
Chronic Disease | 2 | 2017 | 9362 | 0.020 |
Why?
|
Consensus | 1 | 2021 | 3207 | 0.020 |
Why?
|
Oxygen | 1 | 2022 | 4252 | 0.020 |
Why?
|
Rhodamine 123 | 1 | 2010 | 37 | 0.020 |
Why?
|
Cells, Cultured | 2 | 2020 | 18989 | 0.020 |
Why?
|
Rats, Sprague-Dawley | 1 | 2020 | 8108 | 0.020 |
Why?
|
Trypan Blue | 1 | 2009 | 20 | 0.020 |
Why?
|
Anthraquinones | 1 | 2009 | 41 | 0.020 |
Why?
|
Octamer Transcription Factor-3 | 1 | 2010 | 220 | 0.020 |
Why?
|
Animals | 4 | 2023 | 168965 | 0.020 |
Why?
|
Calcification, Physiologic | 1 | 2009 | 170 | 0.020 |
Why?
|
Dose-Response Relationship, Radiation | 1 | 2010 | 876 | 0.020 |
Why?
|
Prospective Studies | 3 | 2018 | 54886 | 0.020 |
Why?
|
Cell Shape | 1 | 2009 | 372 | 0.020 |
Why?
|
Reference Values | 1 | 2014 | 4918 | 0.020 |
Why?
|
Carboplatin | 1 | 2010 | 790 | 0.020 |
Why?
|
Dendritic Cells | 1 | 2018 | 2745 | 0.020 |
Why?
|
Computational Biology | 1 | 2018 | 3567 | 0.020 |
Why?
|
Immunohistochemistry | 2 | 2010 | 11063 | 0.020 |
Why?
|
Mice | 2 | 2023 | 81912 | 0.020 |
Why?
|
Receptors, CXCR4 | 1 | 2010 | 729 | 0.020 |
Why?
|
Epithelium | 1 | 2010 | 1606 | 0.020 |
Why?
|
Drug Resistance, Neoplasm | 2 | 2010 | 5332 | 0.010 |
Why?
|
Echocardiography | 1 | 2017 | 5042 | 0.010 |
Why?
|
Staining and Labeling | 1 | 2009 | 1076 | 0.010 |
Why?
|
Cohort Studies | 2 | 2018 | 41718 | 0.010 |
Why?
|
Computer Simulation | 1 | 2018 | 6260 | 0.010 |
Why?
|
Risk Assessment | 2 | 2016 | 24299 | 0.010 |
Why?
|
Cell Death | 1 | 2009 | 1677 | 0.010 |
Why?
|
Doxorubicin | 1 | 2010 | 2229 | 0.010 |
Why?
|
Radiotherapy | 1 | 2010 | 1500 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 4572 | 0.010 |
Why?
|
Cell Culture Techniques | 1 | 2010 | 1646 | 0.010 |
Why?
|
Cell Division | 1 | 2010 | 4473 | 0.010 |
Why?
|
Glycoproteins | 1 | 2010 | 2200 | 0.010 |
Why?
|
Blood Pressure | 1 | 2017 | 8531 | 0.010 |
Why?
|
Bone Marrow Cells | 1 | 2009 | 2412 | 0.010 |
Why?
|
Survival Rate | 1 | 2014 | 12823 | 0.010 |
Why?
|
Neoplasm Metastasis | 1 | 2010 | 4892 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2020 | 39317 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2017 | 22361 | 0.010 |
Why?
|
Biopsy | 1 | 2010 | 6777 | 0.010 |
Why?
|
Peptides | 1 | 2010 | 4348 | 0.010 |
Why?
|
Age Factors | 1 | 2014 | 18401 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2014 | 22254 | 0.010 |
Why?
|
Cell Movement | 1 | 2009 | 5203 | 0.010 |
Why?
|
Algorithms | 1 | 2016 | 14098 | 0.010 |
Why?
|
Genotype | 1 | 2010 | 13035 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2010 | 12793 | 0.010 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2010 | 8628 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2010 | 17097 | 0.010 |
Why?
|
Phenotype | 1 | 2010 | 16718 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2009 | 11657 | 0.010 |
Why?
|
Child | 1 | 2017 | 80771 | 0.000 |
Why?
|
Adolescent | 1 | 2017 | 89046 | 0.000 |
Why?
|
Antineoplastic Agents | 1 | 2010 | 13650 | 0.000 |
Why?
|